HCSC is the largest customer-owned health insurer in the United States, covering over 16m members across its Blue Cross and Blue Shield health plans in five states.
Smith is a national leader in healthcare, with over 25 years of experience in fiscal, strategic and operations leadership in the health insurance industry.
Smith was named CEO of HCSC in 2020, when he was also recognized as one of Modern Healthcare's 100 Most Influential People in Healthcare.
He is a member of the board of the Economic Club of Chicago, World Business Chicago and Roosevelt University, and a Trustee of the Civic Federation.
Smith began his career at HCSC in 1993 and has served in a wide variety of roles, including business development, corporate transactions and as president of Blue Cross and Blue Shield of Illinois.
HCSC is the fifth largest health insurer in the United States.
Headquartered in Chicago, HCSC has combined annual revenues of approximately USD 46bn, over 272,000 physicians and other providers in its network, more than 24,000 employees and over 16m members across its Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas.
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025